METHODS	Data from two independent multicenter , randomised , double-blind , placebo-controlled , 6-month trials evaluating patients with UC in remission were combined for analysis of a subpopulation of patients who switched from other 5-ASA formulations to MG 1.5 g or placebo upon randomisation .\